This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Treatment and Outcomes in Adolescents With Schizophrenia

S. Charles Schulz, M.D., Robert L. Findling, M.D., Lee Friedman, Ph.D., John T. Kenny, Ph.D., and Alexandria L. Wise

Published: June 1, 1998

Article Abstract

The pharmacologic treatment and assessment of outcomes in adolescents with schizophrenia havebeen inadequately addressed. Structural brain imaging and brain function studies both point to a continuitybetween adolescent and adult stages of schizophrenia. Because the teenage population seemsto be less tolerant of physical side effects, the advent of atypical antipsychotic medications may offerincreased safety and efficacy. Studies support the notion that adolescent illness is associated with amore severe form of schizophrenia and that length of illness before treatment is correlated with longtermoutcome. As a consequence, the authors recommend assertive pharmacologic intervention inadolescents with schizophrenia and future research focused on the issues of treatment and outcome inteenagers suffering a psychotic disorder.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: